Holen Sie sich die Stockscreener-App
21.31
0.24%
0.04
Finanzdaten der Day One Biopharmaceuticals Inc-Aktie (DAWN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
34.99%
53.72
|
39.80 | 33.91 | 30.76 | 29.21 |
Operating Expenses
|
26.75%
81.18
|
64.05 | 68.88 | 71.83 | 94.54 |
| Benefits Costs and Expenses |
-
|
- | - | - | - |
| Costs And Expenses |
26.75%
81.18
|
64.05 | 68.88 | 71.83 | 94.54 |
| Operating Income/Loss |
13.22%
-27.46
|
-24.25 | -34.97 | -41.07 | -65.33 |
| Nonoperating Income/Loss |
7.09%
4.204
|
4.525 | 4.652 | 5.071 | 6.092 |
| Income/Loss From Continuing Operations Before Tax |
34.99%
53.72
|
39.80 | -30.32 | -36.00 | 29.21 |
| Income Tax Expense/Benefit |
-1.976
|
- | - | - | 6.474 |
| Income/Loss From Continuing Operations After Tax |
632.19%
-211.79
|
39.80 | -30.32 | -36.00 | -6.474 |
|
Net Income/Loss
|
-107.32
|
- | -30.32 | -36.00 | -6.474 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
536.20%
-86.04
|
19.73 | 30.32 | 36.00 | 59.24 |
| Basic Average Shares |
99.86%
0.1497
|
103.38 | 103.07 | 102.71 | 3.0693 |
| Diluted Average Shares |
99.86%
0.1497
|
103.38 | 103.07 | 102.71 | 3.0693 |
| Basic Earnings Per Share |
10.53%
-0.21
|
-0.19 | -0.29 | -0.35 | -0.69 |
| Diluted Earnings Per Share |
10.53%
-0.21
|
-0.19 | -0.29 | -0.35 | -0.69 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):